Web Results

en.wikipedia.org/wiki/Nilotinib

Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the ...

medlineplus.gov/druginfo/meds/a608002.html

Sep 15, 2016 ... Nilotinib: learn about side effects, dosage, special precautions, and more on MedlinePlus.

www.rxlist.com/tasigna-drug.htm

Nilotinib drug substance, a monohydrate monohydrochloride, is a white to slightly yellowish to slightly greenish yellow powder with the anhydrous molecular ...

www.hcp.novartis.com/products/Tasigna

TASIGNA® (nilotinib) is indicated for the treatment of newly diagnosed adult patients with Philadelphia chromosome–positive chronic myeloid leukemia (Ph+  ...

www.us.tasigna.com

Learn how TASIGNA® (nilotinib) can be prescribed to treat Ph+ positive chronic myeloid leukemia. See full Safety & Prescribing Info and BOXED WARNING.

www.medicinenet.com/nilotinib/article.htm

Information on the drug nilotinib (Tasigna) prescribed for the treatment of leukemia. Side effects, drug interactions, dosing information, and patient information is ...

pubchem.ncbi.nlm.nih.gov/compound/Nilotinib

Nilotinib is an orally bioavailable aminopyrimidine-derivative Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity. Designed to overcome imatinib ...

livertox.nih.gov/Nilotinib.htm

Nilotinib is a selective tyrosine kinase receptor inhibitor used in the therapy of chronic myelogenous leukemia. Nilotinib therapy is associated with transient ...

www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/nilotinib

Find out what nilotinib is, how you have it and other important information about taking nilotinib.